Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Non-Current Liabilities (2019 - 2024)

Lipocine (LPCN) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $3586.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Other Non-Current Liabilities fell 87.82% year-over-year to $3586.0, compared with a TTM value of $3586.0 through Sep 2024, down 87.82%, and an annual FY2023 reading of $17166.0, down 92.53% over the prior year.
  • Other Non-Current Liabilities was $3586.0 for Q3 2024 at Lipocine, down from $141668.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $37.8 million in Q2 2022 and bottomed at $3586.0 in Q3 2024.
  • Average Other Non-Current Liabilities over 5 years is $3.1 million, with a median of $264099.0 recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities skyrocketed 39.68% in 2022, then tumbled 99.72% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $1.2 million in 2020, then tumbled by 31.99% to $795796.0 in 2021, then plummeted by 71.12% to $229856.0 in 2022, then tumbled by 92.53% to $17166.0 in 2023, then plummeted by 79.11% to $3586.0 in 2024.
  • Business Quant data shows Other Non-Current Liabilities for LPCN at $3586.0 in Q3 2024, $141668.0 in Q2 2024, and $57238.0 in Q1 2024.